1 completed, 1 recruiting. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Cancer of Unknown Primary Site: new trials by email Literature Review of Cancer of Unknown Primary Site trials Research Report on Cancer of Unknown Primary Site
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Treatment of Cancer of Unknown Primary (CUP) F520 combined with chemotherapy, placebo combined with chemotherapy - Cancer of Unknown Primary Site | Phase 2 / Phase 3 | Recruiting | Shandong New Time Pharmaceutical Co., LTD | 402 | 2026-07-08 | 2026-08-12 |
| Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown Primary tissue-of-origin (ORIGIN-PanCA○R) profiling - Cancer of Unknown Primary Site | Phase 3 | Completed | Fudan University | 182 | 2017-09-18 | 2022-01-24 |
Neoplasms, Unknown Primary (2)
Neoplasm Metastasis (2) · Neoplasms (2) · Neoplastic Processes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
Drug Therapy (1)
Fudan University (1) · Shandong New Time Pharmaceutical Co., LTD (1)
China (2)